EUVIMEDEUVIMED entdecken
Crossref

The slow elimination of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene in mice leads to prolonged constitutive androstane receptor activation and hepatomegaly

Yue Gao, Chenghui Cai, Wanyu Zheng, Shicheng Fan, Yifei Zhang, Yanying Zhou, Huilin Li, Jie Yang, Shaoxing Guan, Huichang Bi

Drug Metabolism and Disposition · 2025

DOI: 10.1016/j.dmd.2025.100092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Yue Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-M…. Hauptthemen laut MEDLINE: Hepatomegaly, Receptors, Cytoplasmic and Nuclear, Pyridines, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Shenzhen Science and Technology Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Constitutive androstane receptor (CAR, NR1I3), a nuclear receptor superfamily member, plays a pivotal role in liver size regulation. Murine CAR agonist 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP) was reported to induce hepatomegaly in mice, accompanied by hepatocyte hypertrophy and proliferation. However, whether CAR activation-induced hepatomegaly is reversible and the histological changes during the reversal process remain elusive. In the current study, C57BL/6 mice were administered TCPOBOP for 5 days and sacrificed at different time points after drug withdrawal. The results showed that TCPOBOP-induced hepatomegaly required a long time to reverse, as evidenced by the liver-to-body weight ratio in the TCPOBOP group remaining significantly higher than that in the vehicle group even 120 days after withdrawal. β-catenin and cyclin D1 staining indicated a reduction in hepatocyte size and proliferating cells. To investigate the involved mechanisms, we measured proteins associated with hepatomegaly and liver regeneration termination. The results suggested that yes-associated protein, C-MYC, β-catenin, forkhead box M1, and hepatocyte nuclear factor 4α changed significantly after TCPOBOP withdrawal and functioned at different stages during reversal. Furthermore, we established an ultra performance liquid chromatography-tandem mass spectrometry method to quantify TCPOBOP concentration. The results indicated a long-term hepatic retention of TCPOBOP, which constantly activated CAR and led to sustained hepatomegaly after TCPOBOP withdrawal. Overall, these findings revealed the reversibility of CAR activation-induced hepatomegaly and provided new insights into the safety of CAR as a drug target. Additionally, the results highlighted the importance of considering long-term TCPOBOP accumulation in the liver to avoid potential adverse effects and experimental biases. SIGNIFICANCE STATEMENT: This study demonstrated that hepatic retention of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP) is the fundamental cause of constant constitutive androstane receptor (CAR) activation and sustained hepatomegaly after drug withdrawal, which provided new data for the safety of CAR as a drug target and offered novel insights for CAR manipulation on liver diseases. Notably, when using TCPOBOP as a murine CAR agonist, attention should be paid to its hepatic accumulation and retention to avoid potential experimental biases and adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatomegalyReceptors, Cytoplasmic and NuclearPyridinesLiverAnimalsConstitutive Androstane ReceptorMice, Inbred C57BLMiceMaleHepatocytesCell Proliferation

Stichwörter der Autor:innen

1,4-Bis [2-(3,5-dichloropyridyloxy)] benzeneConstitutive androstane receptorHepatomegalyReversal

Substanzen

Constitutive Androstane Receptor1,4-bis(2-(3,5-dichloropyridyloxy))benzeneReceptors, Cytoplasmic and NuclearPyridinesNr1i3 protein, mouse

Autor:innen und Institutionen

  • NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical…
  • Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Shenzhen Science and Technology Innovation Program
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • China Postdoctoral Science Foundation
  • National Postdoctoral Program for Innovative Talents
  • Guangdong Provincial Medical Research Foundation
  • Guangdong Provincial Pearl River Talents Program

Zitieren

APA

Gao, Y., Cai, C., Zheng, W., Fan, S., Zhang, Y., Zhou, Y., Li, H., Yang, J., Guan, S., & Bi, H. (2025). The slow elimination of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene in mice leads to prolonged constitutive androstane receptor activation and hepatomegaly. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100092

Vancouver

Gao Y, Cai C, Zheng W, Fan S, Zhang Y, Zhou Y, et al. The slow elimination of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene in mice leads to prolonged constitutive androstane receptor activation and hepatomegaly. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100092

BibTeX
@article{Gao2025,
  author = {Gao, Yue and Cai, Chenghui and Zheng, Wanyu and Fan, Shicheng and Zhang, Yifei and Zhou, Yanying and Li, Huilin and Yang, Jie and Guan, Shaoxing and Bi, Huichang},
  title = {The slow elimination of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene in mice leads to prolonged constitutive androstane receptor activation and hepatomegaly},
  journal = {Drug Metabolism and Disposition},
  year = {2025},
  doi = {10.1016/j.dmd.2025.100092}
}
Kostenlos starten →